Cardiovascular implications in preeclampsia: An overview

Circulation

Volumn 130, Issue 8, 2014, Pages 703-714

  Melchiorre, Karen ^a   Sharma, Rajan ^b   Thilaganathan, Basky ^b  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

echocardiography; elasticity imaging techniques; heart function tests; preeclampsia; pregnancy; ventricular remodeling

Indexed keywords

ALFAMETILDOPA; HYDRALAZINE; LABETALOL; NIFEDIPINE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; DIAGNOSTIC PROCEDURE; FLUID BALANCE; HEMODYNAMIC MONITORING; HUMAN; LUNG EDEMA; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUERPERIUM; SHORT COURSE THERAPY; ADULT; CARDIOVASCULAR FUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; PULMONARY EDEMA;

ADULT; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; PULMONARY EDEMA;

EID: 84923364769     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.003664     Document Type: Article

References (86)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-137.
2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.
3. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122-1131.
4. National Collaborating Centre for Women's and Children's Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. National Institute for Health and Clinical Excellence: Guidance. London: RCOG Press; 2010.
5. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP, Mangos G, Moore MP, Muller P, Paech M, Walters B; Society of Obstetric Medicine of Australia and New Zealand. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol. 2009;49:242-246.
6. Magee LA, Helewa M, Moutquin JM, von Dadelszen P; Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(suppl 3):S1-S48.
7. Lindheimer MD, Taler SJ, Cunningham FG. ASH position article: hypertension in pregnancy. J Am Soc Hypertens. 2008;2:484-489.
8. World Health Organisation. The prevention of perinatal mortality and morbidity. WHO Technical Report Series, Report 457. Geneva: WHO; 1970.
9. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. Firsttrimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:133-137.
10. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66:497-506.
11. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066-1074.
12. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008;21:521-526.
13. Chhabra S, Kakani A. Maternal mortality due to eclamptic and noneclamptic hypertensive disorders: a challenge. J Obstet Gynaecol. 2007;27:25-29.
14. Melchiorre K, Thilaganathan B. Maternal cardiac function in preeclampsia. Curr Opin Obstet Gynecol. 2011;23:440-447.
15. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation. 2011;123:1243-1262.
16. De Paco C, Kametas N, Rencoret G, Strobl I, Nicolaides KH. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol. 2008;111:292-300.
17. Bosio PM, McKenna PJ, Conroy R, O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94:978-984.
18. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol. 1990;76:1061-1069.
19. Aardenburg R, Spaanderman ME, Courtar DA, van Eijndhoven HW, de Leeuw PW, Peeters LL. A subnormal plasma volume in formerly preeclamptic women is associated with a low venous capacitance. J Soc Gynecol Investig. 2005;12:107-111.
20. Scholten RR, Sep S, Peeters L, Hopman MT, Lotgering FK, Spaanderman ME. Prepregnancy low-plasma volume and predisposition to preeclampsia and fetal growth restriction. Obstet Gynecol. 2011;117:1085-1093.
21. Gyselaers W, Mullens W, Tomsin K, Mesens T, Peeters L. Role of dysfunctional maternal venous hemodynamics in the pathophysiology of preeclampsia: a review. Ultrasound Obstet Gynecol. 2011;38:123-129.
22. Melchiorre K, Sutherland G, Sharma R, Nanni M, Thilaganathan B. Mid-gestational maternal cardiovascular profile in preterm and term preeclampsia: a prospective study. BJOG. 2013;120:496-504.
23. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873-880.
24. Valensise H, Vasapollo B, Novelli GP, Larciprete G, Romanini ME, Arduini D, Galante A, Romanini C. Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: a pilot study. Ultrasound Obstet Gynecol. 2001;18:450-455.
25. Novelli GP, Vasapollo B, Gagliardi G, Tiralongo GM, Pisani I, Manfellotto D, Giannini L, Valensise H. Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: relationship to placenta-related complications of pregnancy. Ultrasound Obstet Gynecol. 2012;39:430-437.
26. Sep SJ, Schreurs MP, Bekkers SC, Kruse AJ, Smits LJ, Peeters LL. Earlypregnancy changes in cardiac diastolic function in women with recurrent pre-eclampsia and in previously pre-eclamptic women without recurrent disease. BJOG. 2011;118:1112-1119.
27. Sugulle M, Herse F, Hering L, Mockel M, Dechend R, Staff AC. Cardiovascular biomarker midregional proatrial natriuretic peptide during and after preeclamptic pregnancies. Hypertension. 2012;59:395-401.
28. Gafsou B, Lefèvre G, Hennache B, Houfflin Debarge V, Ducloy-Bouthors AS. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy. 2010;29:101-111.
29. Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod. 2008;23:803-806.
30. Baltabaeva A, Marciniak M, Bijnens B, Moggridge J, He FJ, Antonios TF, MacGregor GA, Sutherland GR. Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension. Eur J Echocardiogr. 2008;9:501-508.
31. Bijnens BH, Cikes M, Claus P, Sutherland GR. Velocity and deformation imaging for the assessment of myocardial dysfunction. Eur J Echocardiogr. 2009;10:216-226.
32. Papageorghiou AT, Roberts N. Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol. 2005;17:584-590.
33. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia - a state of sympathetic overactivity. N Engl J Med. 1996;335:1480-1485.
34. Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 1991;17:1072-1077.
35. Jia RZ, Liu XM, Wang X, Wu HQ. Relationship between cardiovascular function and fetal growth restriction in women with pre-eclampsia. Int J Gynaecol Obstet. 2010;110:61-63.
36. Mei S, Gu H, Wang Q, Zhang S, Zeng Y. Pre-eclampsia outcomes in different hemodynamic models. J Obstet Gynaecol Res. 2008;34:179-188.
37. Melchiorre K. Maternal cardiac chamber geometry/function and myocardial performance in pre-eclampsia: a longitudinal study from acute disease in pregnancy to two years post-partum. PhD Thesis, University of "G. d'Annunzio," Chieti, Italy. Accessed June 17, 2011.
38. Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension. 2011;57:85-93.
39. Melchiorre K, Sutherland GR, Watt-Coote I, Liberati M, Thilaganathan B. Severe myocardial impairment and chamber dysfunction in preterm preeclampsia. Hypertens Pregnancy. 2012;31:454-471.
40. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58:709-715.
41. Shahul S, Rhee J, Hacker MR, Gulati G, Mitchell JD, Hess P, Mahmood F, Arany Z, Rana S, Talmor D. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging. 2012;5:734-739.
42. Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens. 2009;27:2257-2264.
43. Borghi C, Esposti DD, Immordino V, Cassani A, Boschi S, Bovicelli L, Ambrosioni E. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol. 2000;183:140-147.
44. Borghi C, Cicero AF, Degli Esposti D, Immordino V, Bacchelli S, Rizzo N, Santi F, Ambrosioni E. Hemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy. Intern Emerg Med. 2011;6:227-234.
45. Simmons LA, Gillin AG, Jeremy RW. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol. 2002;283:H1627-H1633.
46. Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH. Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;32:682-686.
47. Dennis A, Castro J, Simmons S, Carr C, Permezel M, Royse C. Left ventricular systolic and diastolic function and structure in women with untreated preeclampsia. Int J Obstet Anesthes. 2010;19:S11.
48. Tyldum EV, Backe B, Støylen A, Slørdahl SA. Maternal left ventricular and endothelial functions in preeclampsia. Acta Obstet Gynecol Scand. 2012;91:566-573.
49. Hibbard JU, Korcarz CE, Nendaz GG, Lindheimer MD, Lang RM, Shroff SG. The arterial system in pre-eclampsia and chronic hypertension with superimposed pre-eclampsia. BJOG. 2005;112:897-903.
50. Kaihura C, Savvidou MD, Anderson JM, McEniery CM, Nicolaides KH. Maternal arterial stiffness in pregnancies affected by preeclampsia. Am J Physiol Heart Circ Physiol. 2009;297:H759-H764.
51. Avni B, Frenkel G, Shahar L, Golik A, Sherman D, Dishy V. Aortic stiffness in normal and hypertensive pregnancy. Blood Press. 2010;19:11-15.
52. Gyselaers W, Mullens W, Tomsin K, Mesens T, Peeters L. Role of dysfunctional maternal venous hemodynamics in the pathophysiology of preeclampsia: a review. Ultrasound Obstet Gynecol. 2011;38:123-129.
53. Lang RM, Pridjian G, Feldman T, Neumann A, Lindheimer M, Borow KM. Left ventricular mechanics in preeclampsia. Am Heart J. 1991;121:1768-1775.
54. Pàez O, Alfie J, Gorosito M, Puleio P, de Maria M, Prieto N, Majul C. Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of pre-eclampsia. Clin Exp Hypertens. 2009;31:544-552.
55. Lampinen KH, Rönnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens. 2006;24:751-756.
56. Krabbendam I, Maas ML, Thijssen DH, Oyen WJ, Lotgering FK, Hopman MT, Spaanderman ME. Exercise-induced changes in venous vascular function in nonpregnant formerly preeclamptic women. Reprod Sci. 2009;16:414-420.
57. Krabbendam I, Courtar DA, Janssen BJ, Aardenburg R, Peeters LL, Spaanderman ME. Blunted autonomic response to volume expansion in formerly preeclamptic women with low plasma volume. Reprod Sci. 2009;16:105-112.
58. Spaan JJ, Ekhart T, Spaanderman ME, Peeters LL. Remote hemodynamics and renal function in formerly preeclamptic women. Obstet Gynecol. 2009;113:853-859.
59. Edlow AG, Srinivas SK, Elovitz MA. Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2009;200:e60-e62.
60. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944-951.
61. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166-171.
62. Strobl I, Windbichler G, Strasak A, Weiskopf-Schwendinger V, Schweigmann U, Ramoni A, Scheier M. Left ventricular function many years after recovery from pre-eclampsia. BJOG. 2011;118:76-83.
63. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977-2016.
64. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, Rodeheffer RJ. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115:1563-1570.
65. Kuznetsova T, Herbots L, Jin Y, Stolarz-Skrzypek K, Staessen JA. Systolic and diastolic left ventricular dysfunction: from risk factors to overt heart failure. Expert Rev Cardiovasc Ther. 2010;8:251-258.
66. Bauer ST, Cleary KL. Cardiopulmonary complications of pre-eclampsia. Semin Perinatol. 2009;33:158-165.
67. Rutherford JD. Heart failure in pregnancy. Curr Heart Fail Rep. 2012;9:277-281.
68. Lin YS, Tang CH, Yang CY, Wu LS, Hung ST, Hwa HL, Chu PH. Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan. Am J Cardiol. 2011;107:325-330.
69. Bauer TW, Moore GW, Hutchins GM. Morphologic evidence for coronary artery spasm in eclampsia. Circulation. 1982;65:255-259.
70. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147-3197.
71. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Anihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;1:CD002252.
72. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: chronic hypertension in pregnancy. Obstet Gynecol. 2012;119:396-407.
73. Committee on Obstetric Practice. Committee Opinion No. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol. 2011;118:1465-1468.
74. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006;3:CD001449.
75. Nij Bijvank SW, Duvekot JJ. Nicardipine for the treatment of severe hypertension in pregnancy: a review of the literature. Obstet Gynecol Surv. 2010;65:341-347.
76. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276:1328-1331.
77. Dennis AT, Solnordal CB. Acute pulmonary oedema in pregnant women. Anaesthesia. 2012;67:646-659.
78. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K; ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416.
79. Li YH, Novikova N. Pulmonary artery flow catheters for directing management in pre-eclampsia. Cochrane Database Syst Rev. 2012;6:CD008882.
80. Dennis AT. Management of pre-eclampsia: issues for anaesthetists. Anaesthesia. 2012;67:1009-1020.
81. Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N, Lawlor DA. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation. 2012;125:1367-1380.
82. Rich-Edwards JW. The predictive pregnancy: what complicated pregnancies tell us about mother's future cardiovascular risk. Circulation. 2012;125:1336-1338.
83. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122:579-584.
84. Berends AL, de Groot CJ, Sijbrands EJ, Sie MP, Benneheij SH, Pal R, Heydanus R, Oostra BA, van Duijn CM, Steegers EA. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension. 2008;51:1034-1041.
85. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202.
86. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011;306:856-863.